WebThe price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. WebIs Oxford Nanopore Technologies PLC Stock Undervalued? The current Oxford Nanopore Technologies PLC share price is $2.73. The Score for ONTTF is 1, which is 98% below its historic median score of 50, and infers higher risk than normal. ONTTF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Oxford Nanopore Technologies plc (ONTTF) Stock Forum
Web15 de out. de 2024 · About the Square, Inc. stock forecast. As of 2024 April 12, Wednesday current price of SQ stock is 66.420$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Block Inc - Class A stock price has been showing a declining tendency so we believe that similar market segments were not … WebView the latest Oxford Nanopore Technologies PLC (ONTTF) stock price, news, historical charts, analyst ratings and financial information from WSJ. church of god book of minutes
Oxford Nanopore and bioMérieux to Enter Into a Strategic …
Web17 de mar. de 2024 · Get the price compound annual growth rate (cagr) charts for Oxford Nanopore Technologies (ONTTF). 100% free, no signups. Get 20 years of historical price compound annual growth rate (cagr) charts for ONTTF stock and other companies. Tons of financial metrics for serious investors. WebAbout the ON24 Inc stock forecast. As of 2024 April 08, Saturday current price of ONTF stock is 8.610$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. ON24 stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given … WebIs There Any Hope for Illumina Stock? With shares of Illumina (NASDAQ: ILMN) down 37% over the last 12 months and underperforming the market over the last five years, shareholders have had a rough time. As of April 3, regulators in the U.S. were rebuffing its acquisition of Grail, a cancer-testing company that it originally founded and spun off. church of god bookstore cleveland tn